The thumb rule of investing is good management, decent balance sheets & cash flows, and improving ROCE are the core for stock picking in any market scenario.
The earning numbers a mostly in line with estimates and Angel Broking keeps a neutral rating on the stock, says Sarabjit Kour Nangra of Angel Broking.
Shetty says that she has her doubts on a possible revival of revenues saying that the eight drugs bought from Teva for the US market, will take till 2019 to affect Dr Reddy's revenues.